
zzso is an zzso zzso of step 3 of the World Health Organization zzso zzso zzso 

To outline zzso zzso drug zzso zzso dose ratio with other zzso dosing rules, adverse effects and zzso clinical studies in patients with cancer zzso A review of relevant literature on zzso use in cancer pain was zzso 

zzso is used in zzso rotation and administered to patients with cancer pain not responsive to zzso or other strong zzso when intractable zzso adverse effects zzso zzso is considered as the first strong zzso zzso and in patients with zzso zzso zzso possesses different zzso and zzso in comparison to other zzso The advantages of zzso include zzso zzso activity, high oral and zzso zzso long lasting zzso lack of active zzso zzso mainly with zzso low cost and a weak zzso zzso The disadvantages include long and zzso plasma zzso high bound to serum zzso metabolism through zzso system, numerous drug zzso lack of clear zzso dose ratio to other zzso zzso zzso zzso local reactions when administered zzso 

zzso is an important zzso zzso at step 3 of the WHO zzso zzso Future controlled studies may focus on establishment of zzso zzso dose ratio with other zzso and its role as the first strong zzso in comparative studies with zzso adverse effects and quality of life taken into zzso 

